The generic drug maker Par Pharmaceutical Cos. has agreed to be acquired for about $1.84 billion in cash by an affiliate of private investment firm TPG.
Kansas City Star: Business, Kansas City Star: Business
Sun, 07/15/2012 - 10:00pm
The generic drug maker Par Pharmaceutical Cos. has agreed to be acquired for about $1.84 billion in cash by an affiliate of private investment firm TPG.